Additional file 3 of Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer

  • Chi Ying F Huang (Contributor)
  • Jun-Hung Lin (Contributor)
  • Alexander TH Wu (Creator)
  • Pi Lin Sung (Contributor)
  • Mong Hong Lee (Contributor)
  • Sai Ching J. Yeung (Contributor)
  • Ping Chieh Chou (Contributor)
  • Kuo-Chang Wen (Creator)

Dataset

Description

Additional file 3: Figure S3. Metformin at a Clinically Relevant Dosage Inhibits Human Ovarian Cancer Growth. a Growth of human ovarian cancer cells (SKOV3) incubated f with micromolar concentrations of metformin (0.5 mM) for several days. *: p
Date made available2020
PublisherFigshare

Access Dataset

Cite this